Logo image of TMCI

TREACE MEDICAL CONCEPTS INC (TMCI) Stock Price, Quote, News and Overview

NASDAQ:TMCI - Nasdaq - US89455T1097 - Common Stock - Currency: USD

5.76  +0.09 (+1.59%)

After market: 5.76 0 (0%)

TMCI Quote, Performance and Key Statistics

TREACE MEDICAL CONCEPTS INC

NASDAQ:TMCI (6/16/2025, 8:12:16 PM)

After market: 5.76 0 (0%)

5.76

+0.09 (+1.59%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High10.79
52 Week Low4.54
Market Cap362.30M
Shares62.90M
Float46.92M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-04 2025-08-04/amc
IPO04-23 2021-04-23


TMCI short term performance overview.The bars show the price performance of TMCI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

TMCI long term performance overview.The bars show the price performance of TMCI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TMCI is 5.76 USD. In the past month the price decreased by -14.29%. In the past year, price decreased by -3.03%.

TREACE MEDICAL CONCEPTS INC / TMCI Daily stock chart

TMCI Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.04 233.16B
ISRG INTUITIVE SURGICAL INC 67.94 186.03B
BSX BOSTON SCIENTIFIC CORP 37.59 150.15B
SYK STRYKER CORP 30.1 144.12B
MDT MEDTRONIC PLC 15.99 112.76B
BDX BECTON DICKINSON AND CO 12.21 49.33B
EW EDWARDS LIFESCIENCES CORP 28.78 43.89B
IDXX IDEXX LABORATORIES INC 46.38 42.85B
RMD RESMED INC 27.72 36.90B
GEHC GE HEALTHCARE TECHNOLOGY 15.84 33.36B
DXCM DEXCOM INC 50.3 32.55B
STE STERIS PLC 25.82 23.69B

About TMCI

Company Profile

TMCI logo image Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida and currently employs 477 full-time employees. The company went IPO on 2021-04-23. The firm is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. The company has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The company also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The firm sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

Company Info

TREACE MEDICAL CONCEPTS INC

100 Palmetto Park Place

Ponte Vedra FLORIDA 32081 US

CEO: John T. Treace

Employees: 516

TMCI Company Website

TMCI Investor Relations

Phone: 19043735940

TREACE MEDICAL CONCEPTS INC / TMCI FAQ

What is the stock price of TREACE MEDICAL CONCEPTS INC today?

The current stock price of TMCI is 5.76 USD. The price increased by 1.59% in the last trading session.


What is the ticker symbol for TREACE MEDICAL CONCEPTS INC stock?

The exchange symbol of TREACE MEDICAL CONCEPTS INC is TMCI and it is listed on the Nasdaq exchange.


On which exchange is TMCI stock listed?

TMCI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for TREACE MEDICAL CONCEPTS INC stock?

13 analysts have analysed TMCI and the average price target is 10.05 USD. This implies a price increase of 74.43% is expected in the next year compared to the current price of 5.76. Check the TREACE MEDICAL CONCEPTS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TREACE MEDICAL CONCEPTS INC worth?

TREACE MEDICAL CONCEPTS INC (TMCI) has a market capitalization of 362.30M USD. This makes TMCI a Small Cap stock.


How many employees does TREACE MEDICAL CONCEPTS INC have?

TREACE MEDICAL CONCEPTS INC (TMCI) currently has 516 employees.


What are the support and resistance levels for TREACE MEDICAL CONCEPTS INC (TMCI) stock?

TREACE MEDICAL CONCEPTS INC (TMCI) has a support level at 5.66 and a resistance level at 6.18. Check the full technical report for a detailed analysis of TMCI support and resistance levels.


Is TREACE MEDICAL CONCEPTS INC (TMCI) expected to grow?

The Revenue of TREACE MEDICAL CONCEPTS INC (TMCI) is expected to grow by 9.26% in the next year. Check the estimates tab for more information on the TMCI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy TREACE MEDICAL CONCEPTS INC (TMCI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TREACE MEDICAL CONCEPTS INC (TMCI) stock pay dividends?

TMCI does not pay a dividend.


When does TREACE MEDICAL CONCEPTS INC (TMCI) report earnings?

TREACE MEDICAL CONCEPTS INC (TMCI) will report earnings on 2025-08-04, after the market close.


What is the Price/Earnings (PE) ratio of TREACE MEDICAL CONCEPTS INC (TMCI)?

TREACE MEDICAL CONCEPTS INC (TMCI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.8).


What is the Short Interest ratio of TREACE MEDICAL CONCEPTS INC (TMCI) stock?

The outstanding short interest for TREACE MEDICAL CONCEPTS INC (TMCI) is 5.55% of its float. Check the ownership tab for more information on the TMCI short interest.


TMCI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TMCI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to TMCI. Both the profitability and financial health of TMCI have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TMCI Financial Highlights

Over the last trailing twelve months TMCI reported a non-GAAP Earnings per Share(EPS) of -0.8. The EPS increased by 9.09% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -25.74%
ROE -50.3%
Debt/Equity 0.51
Chartmill High Growth Momentum
EPS Q2Q%16.67%
Sales Q2Q%2.86%
EPS 1Y (TTM)9.09%
Revenue 1Y (TTM)7.54%

TMCI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 75% to TMCI. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of 1.6% and a revenue growth 9.26% for TMCI


Ownership
Inst Owners62.71%
Ins Owners22.84%
Short Float %5.55%
Short Ratio5.83
Analysts
Analysts75.38
Price Target10.05 (74.48%)
EPS Next Y1.6%
Revenue Next Year9.26%